ONCOLYTICS BIOTECH : to present data from REO 024 study of pelareorep in combo with Keytruda and chemotherapy at ASCO 2018

Press/Media: Press / Media

PeriodDec 30 2017

Media coverage

1

Media coverage

  • TitleONCOLYTICS BIOTECH : to present data from REO 024 study of pelareorep in combo with Keytruda and chemotherapy at ASCO 2018
    Media name/outlet4 Traders
    CountryUnited States
    Date12/30/17
    PersonsDevalingam Mahalingam